Suramin

epidermal growth factor ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 21617121 Suramin inhibits renal fibrosis in chronic kidney disease. 2011 Jun 1
2 21029725 The NMR solution structure of human epidermal growth factor (hEGF) at physiological pH and its interactions with suramin. 2010 Nov 26 7
3 15350362 Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. 2004 Sep 1
4 10942601 Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. 2000 Aug 25 1
5 9553667 The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen. 1998 Feb 7
6 8738403 Intravesical suramin: a novel agent for the treatment of superficial transitional-cell carcinoma of the bladder. 1996 3
7 7566395 Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells. 1995 Sep 3
8 7897522 Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. 1995 Apr 2
9 8154891 [The effect of suramin on human lung cancer cell line in vitro]. 1994 Apr 2
10 8217281 [Suramin activity in human head and neck squamous cell carcinoma cell lines]. 1993 2
11 8467499 Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells. 1993 Apr 15 1
12 1512858 Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures. 1992 Sep 2
13 1556185 Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. 1992 Apr 4